Virupaksha Organics Ltd. has emerged as a leader in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 2003, the company has built a reputation for innovation, quality, and sustainability. Under the dynamic leadership of Mr. Chandra Mouliswar Reddy Gangavaram, Virupaksha has grown its operations significantly, with state-of-the-art manufacturing facilities in Telangana, India.
The company’s facilities in Kazipally and Pashamylaram are certified by international and national regulatory bodies, including ISO 9001, ISO 14001, ISO 45001, ISO 50001, and GMP standards, ensuring that Virupaksha meets the highest levels of quality and safety in its production processes. These certifications highlight the company’s commitment to environmental sustainability, occupational safety, and best industry practices.
Virupaksha Organics is committed to excellence, innovation, and customer satisfaction, with a focus on developing sustainable solutions for the pharmaceutical industry. The company’s products are trusted by major pharmaceutical firms globally, as it continues to make strides towards becoming a research-driven organization. With a forward-thinking management team and a clear vision for the future, Virupaksha Organics is poised for rapid growth and continues to play a key role in advancing global healthcare.
As part of its corporate social responsibility (CSR), Virupaksha has initiated numerous welfare programs aimed at uplifting local communities and supporting environmental conservation, reinforcing its reputation as a responsible corporate citizen.
With continuous advancements and strategic partnerships, Virupaksha Organics Ltd. is well-positioned to expand its global footprint and contribute to the evolving pharmaceutical landscape.
Other Latest News
- A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News Genetic Engineering & Biotechnology News -New York In this week’s episode, we start with news that Fulcrum Therapeutics is scrapping its lead pipeline program for sickle cell disease following concerns from the FDA about the drug’s risks and benefits. Also on the docket, news of Eli Lilly’s latest spending …
- Ireland should treat corporation tax 'like communion money' as billions in receipts revealed Irish Mirror First holy communion (stock image)(Image: Getty Images/iStockphoto) Ireland should treat the billions of euros it has received in corporation tax "like communion money" and invest it, an opposition party has said. American multinationals now …
- Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval Bastille Post NANJING, China, June 5, 2026 /PRNewswire/ -- NTRK gene fusions have been identified as oncogenic drivers in adult and pediatric patients with pan-solid tumors. A fusion gene is typically formed by the combination of an NTRK gene containing a kinase …
- Pharma Friday – June 5, 2026 Endocrine News An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Exelixis’ CABOMETYX Showed Positive Results Treating NET in Recent Trial On May 30, Exelixis, Inc., announced results from a subgroup analysis of the …
- How disinformation in Congo is worsening Ebola epidemic Deutsche Welle Three weeks since the start of the latest Ebola epidemic in the Democratic Republic of Congo, the facts are: 397 confirmed cases, including 63 confirmed deaths, according to the latest figures reported by the African Union's Africa Centres for Disease …
- Weekly Buzz: PHG, KMDA Win FDA Nod; FULC Halts Pociredir; RMD Closes Noctrix Deal; NVS Paces In IgAN RTTNews This week, the biotech sector saw a wave of regulatory approvals in the U.S., alongside study halts, strategic collaborations, acquisitions, deal closures, and encouraging data readouts. Positive clinical study data readouts spanned multiple therapeutic …
- InnoCare Presents Positive Phase 2b Data For Orelabrutinib In Treating Lupus RTTNews InnoCare Pharma Limited (INCPF), a biopharmaceutical company, on Friday announced promising Phase 2b results for Orelabrutinib in treating systemic lupus erythematosus (SLE). The data was presented at the 2026 Congress of the European Alliance of …
- NH News Recap: Final State House votes, 2026 hopefuls, and an exploding meteor New Hampshire Public Radio State lawmakers wrapped up their session in a series of high-stakes votes this week. Some priorities were pushed across the finish line, while others failed to win support in either the New Hampshire Senate or House. State senators voted to table a …
- DRC: How disinformation worsens Ebola epidemic Deutsche Welle Three weeks since the current Ebola epidemic in the Democratic Republic of Congo was announced, the facts are: 397 confirmed cases, including 63 confirmed deaths, according to the latest figures reported by the African Union's Africa Centres for …
- What SCOTUS’s landmark Hikma skinny label ruling means for pharma patent strategies Intellectual Asset Management The 9-0 decision in favour of the generic seller has implications for patent portfolio, investment diligence and pre-launch strategies, experts tell IAM Register for limited access Register to receive our newsletter and gain limited access to subscriber …
- Korea's Daewoong Pharma partners with China's Chime Biologics for Dupixent biosimilar development Biospectrum Asia Korea's Daewoong Pharma partners with China's Chime Biologics for Dupixent biosimilar development June 5, 2026 | Friday | News Marks Daewoong Pharmaceutical’s full-fledged entry into the biosimilar sector as a key long-term growth engine Chime …
- HHS funding fight kicks off Politico Driving the Day MARKUP MADNESS BEGINS — House lawmakers are scheduled to mark up a bill this morning that proposes a 4 percent reduction in funding for the Department of Health and Human Services — billions less than President Donald Trump requested, but …
- Republican Kelly Ayotte and Democrat Cinde Warmington file for N.H. governor’s race, trade barbs The Boston Globe - Massachusetts When first-term incumbent governors seek reelection in New Hampshire, they rarely lose. Only twice in the past century, in 1926 and 2004, have such candidates suffered electoral defeat. That history is a good omen for Republican incumbent Governor Kelly …
- First patient dosed in Onchilles’ Phase I/II trial of N17350 Hospital Management Onchilles Pharma has dosed the first patient in its Phase I/II clinical trial of N17350, the lead tumour-directed therapeutic candidate, for patients with advanced solid tumours. The open-label, dose-finding and expansion trial is designed to …
- SMALL-CAP MOVERS: Triple takeover, a brain cancer breakthrough and... Proactive UK You couldn't miss Marechale Capital (AIM:MAC) this week, with shares in the London corporate finance boutique more than doubling after it unveiled plans to acquire three businesses in one go. The targets are Stanford Capital Partners, a UK SME-focused …
- Merck to Settle Bulk of Gardasil Suits for About $50 Million Claims Journal Merck & Co. says it will settle a spate of lawsuits that blame the drugmaker’s blockbuster Gardasil cancer vaccine for causing autoimmune ailments that affect young women’s hearts and reproductive systems for an amount that is “not material” to the …
- GOP Senators Join Forces to Ensure Americans Can ‘Manage Their Own Health’ America First Report (DCNF)—Republican Sens. Mike Lee and Tommy Tuberville introduced legislation Thursday aiming to safeguard Americans’ access to homeopathic medicines, the Daily Caller News Foundation has first learned. The Homeopathic Drug Product Safety, Quality, and …
- A healthier gut may be key to cancer care KTVZ - Oregon (CNN) — As a budding specialist in bloodborne cancers like leukemia, Dr. Marcel van den Brink learned how to perform one of the most delicate high-wire acts in medicine: Starting in the early 1990s, many of his seriously ill patients had sophisticated …
- ASCO26 Podcast: an analyst rundown of the best readouts and key trends Pharmaceutical Technology While the 2026 American Society of Clinical Oncology (ASCO) conference may be over for another year, the editorial team at Pharmaceutical Technology are still buzzing from all the potentially paradigm-changing readouts debuted at the conference, with both …
- China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange WFMZ - Pennsylvania SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and autoimmune diseases in China, listed on the Hong Kong Stock Exchange on June 5, 2026 …
- Stocks to Watch, June 5: Ola Electric, Maruti, Inox Clean, CG Power, TVS SCS, Aurobindo Pharma The Hindu Business Line A flurry of corporate announcements marked the day, led by Ola Electric’s successful QIP, TVS Supply Chain’s aerospace venture, Inox Clean Energy’s ₹6,000-crore acquisition, and fresh investments in manufacturing, defence, healthcare and renewable energy. …
- Sensex today | Stock Market Live: Markets turn weak post RBI pause; Sensex down 244 pts, Nifty below 23,350 The Hindu Business Line Morgan Stanley on Titan Maintains OVERWEIGHT rating with a ₹5,182 target price Projects 19% annual jewellery revenue growth through FY30 Aiming to increase market share from 8.5% to 11% Gold exchange programs now drive 50% of revenue: despite stricter …
- Roche chair compares US tariff policy to ‘blackmail’ Swissinfo Schwan identified protectionism by the United States and China as the firm's biggest geopolitical worry. Keystone-SDA The Swiss pharmaceutical company Roche is increasingly concerned by protectionism in the United States and China. At the Swiss …
- Closing Bell: Reality bites the ASX but healthcare finds a pulse Stockhead Listen to Your Heart was the doctor's favourite Roxette song, but he took it way too literally. Pic: Getty Images Investors get a reality check ahead of King Charlie’s birthday bash break Healthcare shines but miners and banks remain under pressure …
- Reality bites the ASX but healthcare finds a pulse Townsville Bulletin Market action aside for half a sec, today is not only one of the best Fridays in recent memory (given it leads into a long weekend to celebrate a big-eared, crown-sporting bloke's birthday)… it also happens to be international Festival of Popular …
- Opening Bell: Sensex, Nifty In Green; Will RBI Power A Market Rally? News X 132 Stock Market Today, June 5 | Opening Bell: Indian benchmark indices opened higher on Friday, June 5, ahead of an important monetary policy decision by the Reserve Bank of India later in the day. The gains were modest, but financials, realty, media, and …
- Azafaros Announces Publication of Phase 2 RAINBOW Study Data for Nizubaglustat in Molecular Genetics and Metabolism Journal Knox County News - Nebraska Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced the publication of clinical data from its Phase 2 (RAINBOW) study in the peer reviewed …
- How I learned to stop worrying and love American monopolies Asia Times For many years, I was a big proponent of the idea that increased market power was harming the US economy in various ways. In the 2010s, in the economics world, circumstantial evidence began to pile up, implicating increased industrial concentration as the …
- Voltas, Auro Pharma, Federal Bank: Stocks to trade— Check price targets, stop loss & more Business Today Indian equity benchmark indices settled little change on Thursday after see-saw moves during the session. Persistent geopolitical tensions weighed on the investors sentiments and traders await RBI monetary policy later today. The BSE Sensex added 13.94 …
- Stocks To Watch: RBI MPC Decision Today; ICICI Bank, Tata Motors In Focus News X 80 Stocks To Watch Today, June 5: Dalal Street likely to kick off Friday’s session on a positive note as markets await RBI’s monetary policy decision; expect the market to remain stock specific with corporate actions, regulatory developments, fundraising …
- Tinygemsbreaks Kairos Pharma Ltd. (NYSE American: KAPA) Highlights Pipeline Expansion And Clinical Milestones In Mid-Year Shareholder Update MENAFN (MENAFN- Investor Brand Network) Kairos Pharma (NYSE American: KAPA) provided a mid-year 2026 update highlighting plans to expand its oncology pipeline through the proposed acquisition of worldwide rights to CL-741, a Phase 1-ready oral c-MET kinase …
- Stocks To Watch: RBI MPC Decision Today; ICICI Bank, Tata Motors In Focus News X 194 Stocks To Watch Today, June 5: Dalal Street likely to kick off Friday’s session on a positive note as markets await RBI’s monetary policy decision; expect the market to remain stock specific with corporate actions, regulatory developments, fundraising …
- Top stocks in news: Rajesh Exports, RIL, Hindalco, Auro Pharma, IndiGo, HDFC AMC, Ola, Lupin Business Today Indian equity benchmark indices settled on a flat note after choppy trading session led by geopolitical tensions and anxiety ahead of RBI monetary policy later today. The BSE Sensex rose 13.94 points, or 0.02 per cent, to close at 74,360.01, while NSE' …
- STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more STAT - Massachusetts Top of the morning to you, and a fine one it is. Clear blue skies and cool breezes are wafting over the Pharmalot campus, where the official mascots are snoozing in their respective corners. This means we are free to focus on the matters at hand — …
- EXCLUSIVE: GOP Senators Join Forces To Ensure Americans Can ‘Manage Their Own Health’ The Daily Caller Republican Sens. Mike Lee and Tommy Tuberville introduced legislation Thursday aiming to safeguard Americans’ access to homeopathic medicines, the Daily Caller News Foundation has first learned. The Homeopathic Drug Product Safety, Quality, and …
- Report raises questions about Platner campaign donations amid anti-corporate messaging WSBT 22 - Indiana (TNND) — Days after a sexting scandal hit Graham Platner in his campaign for U.S. Senate in Maine, Fox News has published an analysis of campaign finance records that suggests Platner was taking money from corporate lobbyists despite railing against big …
- AlphaSense Raises $350M at $7.5B Valuation Ventureburn AlphaSense has officially closed a $350 million funding round, and this has almost doubled the company’s valuation, from $4 billion to $7.5 billion, and taken the total capital raised by the company to over $1 billion. The huge round was led by the …
- ADHD medication shortage reported by pharmaceutical companies Fox News - South Carolina GREENVILLE, S.C. (FOX Carolina) - Some Upstate residents are struggling to find a pharmacy carrying their prescription medication. Multiple people have reached out to FOX Carolina News about being unable to obtain Adderall, Ritalin or their generic forms. …
- Why I Changed My Mind About the “Anti-Monopoly” Movement The Daily Economy For many years, I was a big proponent of the idea that increased market power was harming the U.S. economy in various ways. In the 2010s, in the economics world, circumstantial evidence began piling up that implicated increased industrial concentration as …
- Clinical Trial Execution Is Becoming Pharma’s Competitive Advantage Grit Daily News Bringing a new medicine to market routinely costs more than $1 billion and can take over a decade to complete. Many of the delays driving those costs stem from operational bottlenecks, fragmented data systems, enrollment challenges, and poor visibility …
- EUROTRASH: Van der Breggen Leads Giro & TDF Winners Poll PezCycling News Is this a first — a PEZ EuroTrash led with a women’s cycling article? You ask me (and Jonathan Milan; see below), the women’s Giro is worth leading off with – far more competitive than the men’s Giro. But this edition of EuroTrash serves up plenty of men’s …
- Advancing Precision through Next-Generation Drug Delivery Systems Pharma Tech Outlook By Pharma Tech Outlook | Wednesday, April 29, 2026 Drug delivery has become the limiting factor in translating therapeutic innovation into clinical impact. Breakthroughs in gene editing, RNA therapeutics and targeted oncology continue to outpace the …
- US pharma giant is unhappy with Germany; CEO calls planned healthcare reform ‘terrible’ The Times of India US pharmaceutical giant Eli Lilly has announced that it is halving its massive €2.3 billion ($2.67 billion) investment plan to build a high-tech manufacturing plant in Alzey, Rhineland-Palatinate in what can be seen a major blow to Germany’s industrial …
- New Research: SQL Rivals Python as America’s Most In-Demand Programming Language – and It’s Needed Far Beyond Silicon Valley EIN Presswire Coding skills are increasingly mentioned across job ads in finance, healthcare, manufacturing, and other sectors. Vilnius, Lithuania, June 4, 2026. – As AI transforms the demand for worker skills across the U.S., a new analysis, conducted by Oxylabs, a web …
- Adlib Appoints Kristen Sauter as President & GM of Life Sciences to Accelerate Its Vertical AI Strategy Walla Walla Union-Bulletin - Washington State With more than 20 years building regulatory data and AI solutions inside pharma and biopharma, Sauter joins as Adlib deepens its focus on making AI defensible for clinical, regulatory, and manufacturing workflows, reinforced by its latest platform release …
- <![CDATA[Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut]]> Pharmaceutical Commerce Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast bringing you the latest insights shaping patient access, regulatory policy, and healthcare innovation. I'm your host, and let's get into today's headlines. First up, a new survey from …
- Platner’s anti-corporate crusade hits awkward snag as receipts tell another story Fox News Fox News Edge correspondent Caroline Elliott discusses Maine Senate candidate Graham Platner facing mounting backlash over past Reddit posts on ‘Fox News Live.’ NEWYou can now listen to Fox News articles! Maine Democratic Senate candidate Graham Platner …
- Nighttime line painting on major routes expected to restrict traffic WGAL 8 - Pennsylvania Nighttime line painting on major routes across Dauphin County expected to restrict traffic DRY STRETCH AS THOSE TEMPERATURES CONTINUE TO RISE. WGAL NEWS EIGHT TODAY STARTS NOW. AND THAT’S THE TREND WE’RE SEEING TODAY. SOME TEMPERATURES GOING UP. GOOD …
- SL Targets USD 100 Million Pharma Export Revenue Newsfirst COLOMBO (News 1st) – A programme has been launched by the Export Development Board (EDB) in collaboration with the National Medicines Regulatory Authority (NMRA) to increase the export of locally manufactured and other pharmaceutical products from Sri …
- Top stocks in news: Hero Moto, BHEL, IndiGo, LTM, Rajesh Exports, IEX, Auro Pharma, NBCC, Trent Business Today Despite a quick recovery, Indian equity benchmark indices posted cuts on Wednesday led by the rising tensions between the US and Iran with all eyes set on RBI's monetary policy due later this week. The BSE Sensex dropped 303.67 points, or 0.41 per cent …